OhMyGene, a Molecular Diagnostic initiative of Sagenome Private Ltd, strives to provide reliable and innovative health care solutions for the wellbeing of humanity, utilizing genome-based technologies. Through state-of-the-art lab facilities, top technical human resource, know-how and knowledge base to analyse genetic variations of customers and with precise scientific data analysis, OhMyGene aims to provide robust, accurate and meaningful results of genetic predispositions. These DNA and related healthcare tests will provide significant information about important aspects of genetic health.
The FDA & EMA approved genetic markers for clinical practise includes Cancer Management (tumour markers), Genetic health risks including susceptibility to Cancer, Heart disease & Diabetes, Wellness & Health traits, Personalized Nutrition & Dietary factors, Fitness, Skin & Hair care, Cellular ageing, Allergy, Sensitivity and Infertility management. The precision health care platform offered by OhMyGene, includes design and optimization of using genome profiles for health care, whether for disease diagnosis, intervention and/or prognosis.
The OhMyGene team is led by Dr. M. Ayyappan, an experienced, successful and senior corporate professional with extensive experience in managing healthcare companies.
“The field of health genomics has matured in the past two decades and is beginning to deliver genomic-based interventions for health and health care. Every human being will have huge amounts of genetic variation that actually creates the unique individuality that is seen in a person.
Sagenome provides customized, individualized care for each person’s unique needs. This means breaking from the traditional “one-size-fits-all” approach to nutrition, health care, and wellness that has long characterized the modern healthcare approaches. We achieve this uniqueness through our proprietary precision health care platform called OhMyGene.
Sagenome offers Personalized wellness tests including Risk Assessment Panels for various Inherited Diseases, Diabetes, Obesity, Pharmacogenomics for adjusting drug doses, Women’s health, Men’s health, Personalized nutrition and Personalized cosmetic care. Our Clinical DNA tests include tests for cancer treatment, cardiovascular conditions, gynaecology conditions etc. Read More
Sagenome, through its services, is committed to wellbeing of the humanity.”.
Our Vision
To become a global, reliable provider of genomic-based interventions, by continuous research and innovation, enabling people to live with confidence, thereby ensuring the wellness of the society.
Our Mission
To develop products and services to address remedies, therapeutic and preventive, based on the outcome of Gene testing.
To establish a network of gene testing centers with updated technology making it affordable and accessible to a large population.
To offer personalized medicines/ nutrition/ support system based on genomic testing.
To establish a state-of-the-art academic learning institute in the area of molecular genetics.
To carry out continuous R&D through linkages with research institutes of international repute to accurately assess genetic health risk/ disease conditions.
To establish a network of affiliate Multi-specialty hospitals focused on specialized individualized treatment based on genomic testing.
To develop a proprietary high performance computer based Artificial Intelligence (AI) algorithms to facilitate early therapeutic or preventive interventions.
The OhMyGene Team
Chief Advancement Officer
FM & EA to Chairman